Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2

FJ Candel, P Barreiro, M Salavert, A Cabello… - Viruses, 2023 - mdpi.com
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …

COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response

I Gur, A Giladi, YN Isenberg, A Neuberger… - Acta haematologica, 2022 - karger.com
Background: The clinical presentation of coronavirus disease 19 (COVID-19) is the result of
intricate interactions between the novel coronavirus and the immune system. In patients with …

Transforming the information system for research in primary care (SIDIAP) in Catalonia to the OMOP common data model and its use for COVID-19 research

B Raventós, S Fernández-Bertolín, M Aragón… - Clinical …, 2023 - Taylor & Francis
Purpose The primary aim of this work was to convert the Information System for Research in
Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes …

Impact of COVID-19 in patients with multiple myeloma based on a global data network

J Martinez-Lopez, G Hernandez-Ibarburu… - Blood cancer …, 2021 - nature.com
The COVID-19 pandemic has represented a major cause of morbidity/mortality worldwide,
overstressing health systems. Multiple myeloma (MM) patients show an increased risk for …

High viral loads: what drives fatal cases of COVID-19 in vaccinees?–an autopsy study

K Hirschbühl, T Schaller, B Märkl, R Claus, E Sipos… - Modern …, 2022 - nature.com
The rate of SARS-CoV-2 infections in vaccinees has become a relevant serious issue. This
study aimed to determine the causes of death, histological organ alteration, and viral spread …

[HTML][HTML] Multimorbidity and SARS-CoV-2–Related Outcomes: Analysis of a Cohort of Italian Patients

A Catalano, L Dansero, W Gilcrease… - JMIR Public Health …, 2023 - publichealth.jmir.org
Background: Since the outbreak of the COVID-19 pandemic, identifying the main risk factors
has been imperative to properly manage the public health challenges that the pandemic …

Impact of the COVID-19 pandemic on cancer diagnosis in Madrid (Spain) based on the RTMAD tumor registry (2019–2021)

G Garrido-Cantero, F Longo, J Hernández-González… - Cancers, 2023 - mdpi.com
Simple Summary The COVID-19 pandemic has caused a significant disruption to cancer
diagnosis, treatment and prevention. According to standardized incidence ratios, the large …

Effectiveness of COVID-19 vaccines against severe COVID-19 among patients with cancer in Catalonia, Spain

F Lazar Neto, N Mercadé-Besora, B Raventós… - Nature …, 2024 - nature.com
Patients with cancer were excluded from pivotal randomized clinical trials of COVID-19
vaccine products, and available observational evidence on vaccine effectiveness (VE) …

Ten-year probabilities of death due to cancer and cardiovascular disease among breast cancer patients diagnosed in north-eastern Spain

R Clèries, A Ameijide, M Buxó, M Vilardell… - International journal of …, 2022 - mdpi.com
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical
interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC …

[HTML][HTML] Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis

L Wang, Y Wang, X Cheng, X Li, J Li - Translational Oncology, 2023 - Elsevier
Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …